Search research articles
Contact Us
Filters
Showing results (261-270 of 292) with videos related to
Page
of 30
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 1, 1986
Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures
B R MacDonald, G R Mundy, S Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1986
Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro
K J Ibbotson, J Harrod, M Gowen, et al.
The New England Journal of Medicine
|
August 27, 1987
Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells
I R Garrett, B G Durie, G E Nedwin, et al.
Clinical Orthopaedics and Related Research
|
November 1, 1993
Characterization of a cell line derived from a human giant cell tumor that stimulates osteoclastic bone resorption
R O Oreffo, G J Marshall, M Kirchen, et al.
The Journal of Clinical Investigation
|
October 1, 1996
Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis
T A Guise, J J Yin, S D Taylor, et al.
The Journal of Clinical Investigation
|
June 1, 1993
Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo
T Yoneda, C Lowe, C H Lee, et al.
Cancer Research
|
August 15, 1991
The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice
T Yoneda, R M Lyall, M M Alsina, et al.
Endocrinology
|
June 1, 1990
A noncyclical analog of salmon calcitonin (N alpha-propionyl Di-Ala1,7,des-Leu19 sCT) retains full potency without inducing anorexia in rats
A J Yates, G E Gutierrez, I R Garrett, et al.
The Journal of Clinical Investigation
|
June 1, 1995
Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo
J de la Mata, H L Uy, T A Guise, et al.
Blood
|
February 25, 1999
Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease
S L Dallas, I R Garrett, B O Oyajobi, et al.
Page
of 30
Search research articles
Search
Showing results (261-270 of 292) with videos related to
Sort By:
Page
of 30
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 1, 1986
Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures
B R MacDonald, G R Mundy, S Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1986
Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro
K J Ibbotson, J Harrod, M Gowen, et al.
The New England Journal of Medicine
|
August 27, 1987
Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells
I R Garrett, B G Durie, G E Nedwin, et al.
Clinical Orthopaedics and Related Research
|
November 1, 1993
Characterization of a cell line derived from a human giant cell tumor that stimulates osteoclastic bone resorption
R O Oreffo, G J Marshall, M Kirchen, et al.
The Journal of Clinical Investigation
|
October 1, 1996
Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis
T A Guise, J J Yin, S D Taylor, et al.
The Journal of Clinical Investigation
|
June 1, 1993
Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo
T Yoneda, C Lowe, C H Lee, et al.
Cancer Research
|
August 15, 1991
The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice
T Yoneda, R M Lyall, M M Alsina, et al.
Endocrinology
|
June 1, 1990
A noncyclical analog of salmon calcitonin (N alpha-propionyl Di-Ala1,7,des-Leu19 sCT) retains full potency without inducing anorexia in rats
A J Yates, G E Gutierrez, I R Garrett, et al.
The Journal of Clinical Investigation
|
June 1, 1995
Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo
J de la Mata, H L Uy, T A Guise, et al.
Blood
|
February 25, 1999
Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease
S L Dallas, I R Garrett, B O Oyajobi, et al.
Page
of 30